214 related articles for article (PubMed ID: 15543330)
1. Thrombin activatable fibrinolysis inhibitor and its fibrinolytic effect in normal pregnancy.
Mousa HA; Downey C; Alfirevic Z; Toh CH
Thromb Haemost; 2004 Nov; 92(5):1025-31. PubMed ID: 15543330
[TBL] [Abstract][Full Text] [Related]
2. Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?
Antovic JP; Rafik Hamad R; Antovic A; Blombäck M; Bremme K
Thromb Haemost; 2002 Oct; 88(4):644-7. PubMed ID: 12362237
[TBL] [Abstract][Full Text] [Related]
3. Characterization of thrombin activatable fibrinolysis inhibitor in normal and acquired haemostatic dysfunction.
Toh CH
Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S69-71. PubMed ID: 14567541
[TBL] [Abstract][Full Text] [Related]
4. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
Antovic JP; Blombäck M
Thromb Res; 2002 Apr; 106(1):59-62. PubMed ID: 12165290
[TBL] [Abstract][Full Text] [Related]
5. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.
Miljić P; Heylen E; Willemse J; Djordjević V; Radojković D; Colović M; Elezović I; Hendriks D
Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():74-8. PubMed ID: 20229688
[TBL] [Abstract][Full Text] [Related]
6. The paradoxical antifibrinolytic effect of dabigatran and argatroban in the presence of soluble thrombomodulin is unrelated to protein C-dependent increase of thrombin generation.
Incampo F; Carrieri C; Semeraro N; Colucci M
Thromb Res; 2014 Nov; 134(5):1110-6. PubMed ID: 25193406
[TBL] [Abstract][Full Text] [Related]
7. The impact of the endothelial protein C receptor on thrombin generation and clot lysis.
Pepler L; Wu C; Dwivedi DJ; Wu C; Kim PY; Liaw PC
Thromb Res; 2017 Apr; 152():30-37. PubMed ID: 28219843
[TBL] [Abstract][Full Text] [Related]
8. Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy.
Akinci B; Demir T; Saygili S; Yener S; Alacacioglu I; Saygili F; Bayraktar F; Yesil S
Diabetes Res Clin Pract; 2008 Jul; 81(1):93-6. PubMed ID: 18406001
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension.
Yaoita N; Satoh K; Satoh T; Sugimura K; Tatebe S; Yamamoto S; Aoki T; Miura M; Miyata S; Kawamura T; Horiuchi H; Fukumoto Y; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1293-301. PubMed ID: 27102961
[TBL] [Abstract][Full Text] [Related]
10. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
Mosnier LO; Meijers JC; Bouma BN
Thromb Haemost; 2001 Oct; 86(4):1040-6. PubMed ID: 11686322
[TBL] [Abstract][Full Text] [Related]
11. Changes in activity of plasma thrombin activatable fibrinolysis inhibitor in pregnancy.
Watanabe T; Minakami H; Sakata Y; Matsubara S; Sato I; Suzuki M
Gynecol Obstet Invest; 2004; 58(1):19-21. PubMed ID: 15004439
[TBL] [Abstract][Full Text] [Related]
12. Thrombin-activatable fibrinolysis inhibitor.
Marx PF
Curr Med Chem; 2004 Sep; 11(17):2335-48. PubMed ID: 15379716
[TBL] [Abstract][Full Text] [Related]
13. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
[TBL] [Abstract][Full Text] [Related]
14. Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis.
Bouma BN; Mosnier LO
Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):375-81. PubMed ID: 15692247
[TBL] [Abstract][Full Text] [Related]
15. Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.
Antovic JP; Antovic A; He S; Tengborn L; Blombäck M
Haemophilia; 2002 Nov; 8(6):781-6. PubMed ID: 12410647
[TBL] [Abstract][Full Text] [Related]
16. Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).
Grosso G; Vikerfors A; Woodhams B; Adam M; Bremme K; Holmström M; Ågren A; Eelde A; Bruzelius M; Svenungsson E; Antovic A
Thromb Res; 2017 Oct; 158():168-173. PubMed ID: 28669410
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system.
Zorio E; Castelló R; Falcó C; España F; Osa A; Almenar L; Aznar J; Estellés A
Br J Haematol; 2003 Sep; 122(6):958-65. PubMed ID: 12956767
[TBL] [Abstract][Full Text] [Related]
18. Higher thrombin activatable fibrinolysis inhibitor levels are associated with inflammation in attack-free familial Mediterranean fever patients.
Bavbek N; Ceri M; Akdeniz D; Kargili A; Duranay M; Erdemli K; Akcay A; Guz G
Ren Fail; 2014 Jun; 36(5):743-7. PubMed ID: 24580410
[TBL] [Abstract][Full Text] [Related]
19. Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies.
Martínez-Zamora MA; Tassies D; Carmona F; Espinosa G; Cervera R; Reverter JC; Balasch J
J Reprod Immunol; 2010 Nov; 86(2):133-40. PubMed ID: 20594598
[TBL] [Abstract][Full Text] [Related]
20. Levels of thrombin activatable fibrinolysis inhibitor in gestational diabetes mellitus.
Gumus II; Kargili A; Karakurt F; Kasapoglu B; Derbent A; Kaygusuz I; Koca C; Sevgili S
Gynecol Endocrinol; 2013 Apr; 29(4):327-30. PubMed ID: 23327722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]